½ÃÀ庸°í¼­
»óǰÄÚµå
1598390

¿­ Á¦°Å ±â±â ½ÃÀå : ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Thermal Ablation Devices Market by Technology (Hydrothermal Ablation, Laser Ablation, Microwave Ablation), End User (Ambulatory Surgical Centers (ASCs), Hospitals, Specialty Clinics) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿­ Á¦°Å ±â±â ½ÃÀåÀº 2023³â¿¡ 28¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 31¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.31%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 53¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

¿­ Á¦°Å ±â±âÀÇ ¹üÀ§¿¡´Â °íÁÖÆÄ ÀýÁ¦, ¸¶ÀÌÅ©·ÎÆÄ ÀýÁ¦, ·¹ÀÌÀú ÀýÁ¦ µî ¿­ ¹ß»ý ¹æ¹ýÀ» »ç¿ëÇÏ¿© Á¾¾ç°ú °°Àº Á¶Á÷À» Á¦°ÅÇϰųª ÆÄ±«ÇÏ´Â ÀýÂ÷°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Àåºñ´Â ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ÇʼöÀûÀ̸ç, ȸº¹ ½Ã°£À» ´ÜÃàÇϰí ÁÖº¯ Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸç, ƯÈ÷ Á¾¾çÇÐ ÁßÀç, ½ÉÀåÇÐ ¹× ºÎÀΰú¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡´Â º´¿ø, ¼ö¼ú¼¾ÅÍ, °£¾Ï, ½ÅÀå¾Ï, Æó¾Ï, °ñ¾Ï ¼ö¼úÀ» À§ÇÑ Àü¹® Ŭ¸®´ÐÀÌ Æ÷ÇԵǸç, Á¤¸Æ·ù ¹× ¸¸¼º ÅëÁõ °ü¸®¿¡µµ »õ·Î¿î ÀÀ¿ë ºÐ¾ß°¡ µîÀåÇϰí ÀÖ½À´Ï´Ù. ¾Ï À¯º´·ü Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡´Âµ¥, ÀÌ·¯ÇÑ Áúº´Àº È¿°úÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, AI ÅëÇÕ ÀåÄ¡¿Í °°Àº ±â¼ú ¹ßÀüÀº ÀýÁ¦¼úÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃÄÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¿Ü·¡ ȯÀÚ Ä¡·á ȯ°æ¿¡ ´ëÇÑ ¼ö¿ä´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ½ÂÀÎ, ³ôÀº Àåºñ ºñ¿ë, ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú °°Àº °úÁ¦´Â ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå Âü¿©ÀÚµéÀº ÈÞ´ë¿ë ±â±âÀÇ ¹ßÀüÀ» ¸ð»öÇϰí ÀýÁ¦ ¿ä¹ýÀÇ Àû¿ë ¹üÀ§¸¦ È®´ëÇϱâ À§ÇÑ ¿¬±¸¸¦ ¼öÇàÇÔÀ¸·Î½á ÀÌ·¯ÇÑ °úÁ¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ½À´Ï´Ù. °³¹ß, ¿ø°Ý ¸ð´ÏÅ͸µ ±â´É¿¡ ´ëÇÑ ÅõÀÚ, ÀúÀÚ¿ø ȯ°æ¿¡ ¸Â´Â ºñ¿ë È¿À²ÀûÀÎ ±â±â °³¹ß µîÀÇ ±âȸ°¡ ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¸¦ À§ÇÑ ±³À° ÇÁ·Î±×·¥¿¡ ÁßÁ¡À» µÎ´Â °Íµµ ½ÃÀå ¼ö¿ë°ú ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ °üÁ¡¿¡¼­ º¼ ¶§, ¿­ ÀýÁ¦¼ú°ú ¸é¿ª ¿ä¹ý°ú °°Àº ´Ù¸¥ Ä¡·á¹ý°úÀÇ ½Ã³ÊÁö È¿°ú¿¡ ´ëÇÑ Å½±¸¿Í ¾ÈÀü¼º°ú À¯È¿¼ºÀ» ³ôÀ̱â À§ÇÑ ¿¡³ÊÁö Àü´Þ ½Ã½ºÅÛ °³¼±Àº À¯¸ÁÇÑ ¿¬±¸ ¹æÇâÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ¿­ ÀýÁ¦ ÀåÄ¡ ½ÃÀåÀº ±â¼ú ¹ßÀüÀ» Ȱ¿ëÇϰí ÇöÀç ½ÃÀåÀÇ ÇѰ踦 ±Øº¹ÇÔÀ¸·Î½á ¼ºÀåÇÒ ¼ö ÀÖ´Â ¿©°ÇÀÌ Á¶¼ºµÇ¾î ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 28¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 31¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 53¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 9.31%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿­ Á¦°Å ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿­ Á¦°Å ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°è ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡
    • ÃÖ¼Ò Ä§½ÀÀû Ä¡·á·ÎÀÇ Àüȯ
    • ÀÇ·á ½Ã¼³¿¡¼­ ÈÞ´ë¿ë ¿­ Á¦°Å ÀåÄ¡ »ç¿ë Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿­ Á¦°Å ±â±âÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ¿­ Á¦°Å ±â±âÀÇ ±â¼úÀû Áøº¸
    • ¿­ ÀýÁ¦ ÀåÄ¡ °³¹ßÀ» À§ÇÑ À¯¸®ÇÑ ÀÚ±Ý Á¶´Þ »óȲ
  • ½ÃÀå °úÁ¦
    • ¿­ Á¦°Å ±â±âÀÇ ±â¼úÀû ¹®Á¦

Portre's Five Forces: ¿­ÀýÁ¦ Àåºñ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ¿­ Á¦°Å ±â±â ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿­ Á¦°Å ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿­ Á¦°Å ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¿­ÀýÁ¦ Àåºñ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

¿­ Á¦°Å ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© º¥´õ°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ À§Ä¡¸¦ °­È­Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¿­ ÀýÁ¦ ÀåÄ¡ ½ÃÀå¿¡¼­ÀÇ º¥´õÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿­ Á¦°Å ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ¿­ Á¦°Å ±â±â ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

¿­ Á¦°Å ±â±â ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

    Á¦6Àå ¿­ Á¦°Å ±â±â ½ÃÀå : ±â¼úº°

    • ¼ö¿­ ÀýÁ¦
    • ·¹ÀÌÀú ÀýÁ¦
    • ¸¶ÀÌÅ©·ÎÆÄ ÀýÁ¦
    • °íÁÖÆÄ ÀýÁ¦
    • ÃÊÀ½ÆÄ ÀýÁ¦

    Á¦7Àå ¿­ Á¦°Å ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • º´¿ø
    • Àü¹® Ŭ¸®´Ð

    Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿­ Á¦°Å ±â±â ½ÃÀå

    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
    • ¹Ì±¹

    Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿­ Á¦°Å ±â±â ½ÃÀå

    • È£ÁÖ
    • Áß±¹
    • Àεµ
    • Àεµ³×½Ã¾Æ
    • ÀϺ»
    • ¸»·¹À̽þÆ
    • Çʸ®ÇÉ
    • ½Ì°¡Æ÷¸£
    • Çѱ¹
    • ´ë¸¸
    • ű¹
    • º£Æ®³²

    Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿­ Á¦°Å ±â±â ½ÃÀå

    • µ§¸¶Å©
    • ÀÌÁýÆ®
    • Çɶõµå
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • À̽º¶ó¿¤
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ³ªÀÌÁö¸®¾Æ
    • ³ë¸£¿þÀÌ
    • Æú¶õµå
    • īŸ¸£
    • ·¯½Ã¾Æ
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ½ºÆäÀÎ
    • ½º¿þµ§
    • ½ºÀ§½º
    • ÅÍŰ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ¿µ±¹

    Á¦11Àå °æÀï ±¸µµ

    • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
    • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
    • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Àü·« ºÐ¼®°ú Á¦¾È

    ±â¾÷ ¸®½ºÆ®

    • Abbott Laboratories
    • AngioDynamics, Inc.
    • AtriCure, Inc.
    • biolitec AG
    • Biotronik
    • Boston Scientific Corporation
    • CONMED Corporation
    • Eufoton srl
    • HealthTronics, Inc.
    • Hologic, Inc.
    • Johnson & Johnson Services, Inc.
    • Koninklijke Philips NV
    • Lumenis Be Ltd.
    • Medtronic plc
    • Merit Medical Systems
    • Olympus Europa SE & Co. KG
    • RF Medical Co. Ltd.
    • Sciton, Inc.
    • Smith & Nephew PLC
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Corporation
    • Varian Medical Systems
    • Venclose Inc.
    LSH

    The Thermal Ablation Devices Market was valued at USD 2.85 billion in 2023, expected to reach USD 3.11 billion in 2024, and is projected to grow at a CAGR of 9.31%, to USD 5.32 billion by 2030.

    The scope of thermal ablation devices encompasses the use of heat-generating methods to remove or destroy tissues, such as tumors, via procedures that include radiofrequency ablation, microwave ablation, and laser ablation. These devices are essential for minimally invasive surgeries, offering quicker recovery times and minimal damage to surrounding tissues, making them critical in oncology interventions, cardiology, and gynecology, among others. End-users include hospitals, surgical centers, and specialized clinics catering to procedures in liver, kidney, lung, and bone cancers, with emerging applications in varicose veins and chronic pain management. The increasing prevalence of cancer and the rising geriatric population significantly influence market growth, as these conditions often require effective treatment solutions. Additionally, technological advancements like AI-integrated devices enhance the precision and efficiency of ablation procedures, presenting lucrative opportunities. The demand for outpatient care settings further stimulates market expansion. However, challenges such as stringent regulatory approvals, high equipment costs, and a shortage of skilled professionals may hinder growth. Market players can explore the advancement of portable devices and conduct studies to expand the applicable range of ablation therapies to address these challenges. Opportunities lie in tapping into emerging markets, investing in remote monitoring capabilities, and developing cost-effective devices tailored for lower-resource settings. Emphasizing training programs for healthcare providers can also catalyze market acceptance and growth. From an innovation standpoint, areas such as exploring synergistic effects of combining thermal ablation with other treatment modalities, like immunotherapy, and refining energy delivery systems for enhanced safety and efficacy represent promising research directions. Overall, the thermal ablation device market is poised for growth by leveraging technological advancements and addressing current market limitations.

    KEY MARKET STATISTICS
    Base Year [2023] USD 2.85 billion
    Estimated Year [2024] USD 3.11 billion
    Forecast Year [2030] USD 5.32 billion
    CAGR (%) 9.31%

    Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Thermal Ablation Devices Market

    The Thermal Ablation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

    • Market Drivers
      • Increasing incidence of chronic diseases worldwide
      • Inclination towards minimally invasive medical treatments
      • Rising use of portable thermal ablation devices in medical facilities
    • Market Restraints
      • High cost of thermal ablation devices
    • Market Opportunities
      • Technological advancements in thermal ablation devices
      • Favorable funding landscape for development of thermal ablation devices
    • Market Challenges
      • Technical issues associated with thermal ablation devices

    Porter's Five Forces: A Strategic Tool for Navigating the Thermal Ablation Devices Market

    Porter's five forces framework is a critical tool for understanding the competitive landscape of the Thermal Ablation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

    PESTLE Analysis: Navigating External Influences in the Thermal Ablation Devices Market

    External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Thermal Ablation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

    Market Share Analysis: Understanding the Competitive Landscape in the Thermal Ablation Devices Market

    A detailed market share analysis in the Thermal Ablation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

    FPNV Positioning Matrix: Evaluating Vendors' Performance in the Thermal Ablation Devices Market

    The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Thermal Ablation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

    Strategy Analysis & Recommendation: Charting a Path to Success in the Thermal Ablation Devices Market

    A strategic analysis of the Thermal Ablation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

    Key Company Profiles

    The report delves into recent significant developments in the Thermal Ablation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., AtriCure, Inc., biolitec AG, Biotronik, Boston Scientific Corporation, CONMED Corporation, Eufoton srl, HealthTronics, Inc., Hologic, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips NV, Lumenis Be Ltd., Medtronic plc, Merit Medical Systems, Olympus Europa SE & Co. KG, RF Medical Co. Ltd., Sciton, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Varian Medical Systems, and Venclose Inc..

    Market Segmentation & Coverage

    This research report categorizes the Thermal Ablation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

    • Based on Technology, market is studied across Hydrothermal Ablation, Laser Ablation, Microwave Ablation, Radiofrequency Ablation, and Ultrasound Ablation.
    • Based on End User, market is studied across Ambulatory Surgical Centers (ASCs), Hospitals, and Specialty Clinics.
    • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

    The report offers a comprehensive analysis of the market, covering key focus areas:

    1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

    2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

    3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

    4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

    5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

    The report also answers critical questions to aid stakeholders in making informed decisions:

    1. What is the current market size, and what is the forecasted growth?

    2. Which products, segments, and regions offer the best investment opportunities?

    3. What are the key technology trends and regulatory influences shaping the market?

    4. How do leading vendors rank in terms of market share and competitive positioning?

    5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

    Table of Contents

    1. Preface

    • 1.1. Objectives of the Study
    • 1.2. Market Segmentation & Coverage
    • 1.3. Years Considered for the Study
    • 1.4. Currency & Pricing
    • 1.5. Language
    • 1.6. Stakeholders

    2. Research Methodology

    • 2.1. Define: Research Objective
    • 2.2. Determine: Research Design
    • 2.3. Prepare: Research Instrument
    • 2.4. Collect: Data Source
    • 2.5. Analyze: Data Interpretation
    • 2.6. Formulate: Data Verification
    • 2.7. Publish: Research Report
    • 2.8. Repeat: Report Update

    3. Executive Summary

    4. Market Overview

    5. Market Insights

    • 5.1. Market Dynamics
      • 5.1.1. Drivers
        • 5.1.1.1. Increasing incidence of chronic diseases worldwide
        • 5.1.1.2. Inclination towards minimally invasive medical treatments
        • 5.1.1.3. Rising use of portable thermal ablation devices in medical facilities
      • 5.1.2. Restraints
        • 5.1.2.1. High cost of thermal ablation devices
      • 5.1.3. Opportunities
        • 5.1.3.1. Technological advancements in thermal ablation devices
        • 5.1.3.2. Favorable funding landscape for development of thermal ablation devices
      • 5.1.4. Challenges
        • 5.1.4.1. Technical issues associated with thermal ablation devices
    • 5.2. Market Segmentation Analysis
    • 5.3. Porter's Five Forces Analysis
      • 5.3.1. Threat of New Entrants
      • 5.3.2. Threat of Substitutes
      • 5.3.3. Bargaining Power of Customers
      • 5.3.4. Bargaining Power of Suppliers
      • 5.3.5. Industry Rivalry
    • 5.4. PESTLE Analysis
      • 5.4.1. Political
      • 5.4.2. Economic
      • 5.4.3. Social
      • 5.4.4. Technological
      • 5.4.5. Legal
      • 5.4.6. Environmental

    6. Thermal Ablation Devices Market, by Technology

    • 6.1. Introduction
    • 6.2. Hydrothermal Ablation
    • 6.3. Laser Ablation
    • 6.4. Microwave Ablation
    • 6.5. Radiofrequency Ablation
    • 6.6. Ultrasound Ablation

    7. Thermal Ablation Devices Market, by End User

    • 7.1. Introduction
    • 7.2. Ambulatory Surgical Centers (ASCs)
    • 7.3. Hospitals
    • 7.4. Specialty Clinics

    8. Americas Thermal Ablation Devices Market

    • 8.1. Introduction
    • 8.2. Argentina
    • 8.3. Brazil
    • 8.4. Canada
    • 8.5. Mexico
    • 8.6. United States

    9. Asia-Pacific Thermal Ablation Devices Market

    • 9.1. Introduction
    • 9.2. Australia
    • 9.3. China
    • 9.4. India
    • 9.5. Indonesia
    • 9.6. Japan
    • 9.7. Malaysia
    • 9.8. Philippines
    • 9.9. Singapore
    • 9.10. South Korea
    • 9.11. Taiwan
    • 9.12. Thailand
    • 9.13. Vietnam

    10. Europe, Middle East & Africa Thermal Ablation Devices Market

    • 10.1. Introduction
    • 10.2. Denmark
    • 10.3. Egypt
    • 10.4. Finland
    • 10.5. France
    • 10.6. Germany
    • 10.7. Israel
    • 10.8. Italy
    • 10.9. Netherlands
    • 10.10. Nigeria
    • 10.11. Norway
    • 10.12. Poland
    • 10.13. Qatar
    • 10.14. Russia
    • 10.15. Saudi Arabia
    • 10.16. South Africa
    • 10.17. Spain
    • 10.18. Sweden
    • 10.19. Switzerland
    • 10.20. Turkey
    • 10.21. United Arab Emirates
    • 10.22. United Kingdom

    11. Competitive Landscape

    • 11.1. Market Share Analysis, 2023
    • 11.2. FPNV Positioning Matrix, 2023
    • 11.3. Competitive Scenario Analysis
    • 11.4. Strategy Analysis & Recommendation

    Companies Mentioned

    • 1. Abbott Laboratories
    • 2. AngioDynamics, Inc.
    • 3. AtriCure, Inc.
    • 4. biolitec AG
    • 5. Biotronik
    • 6. Boston Scientific Corporation
    • 7. CONMED Corporation
    • 8. Eufoton srl
    • 9. HealthTronics, Inc.
    • 10. Hologic, Inc.
    • 11. Johnson & Johnson Services, Inc.
    • 12. Koninklijke Philips NV
    • 13. Lumenis Be Ltd.
    • 14. Medtronic plc
    • 15. Merit Medical Systems
    • 16. Olympus Europa SE & Co. KG
    • 17. RF Medical Co. Ltd.
    • 18. Sciton, Inc.
    • 19. Smith & Nephew PLC
    • 20. Stryker Corporation
    • 21. Teleflex Incorporated
    • 22. Terumo Corporation
    • 23. Varian Medical Systems
    • 24. Venclose Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦